颈动脉分子钙化:[18F]氟化钠PET/CT与心血管及血栓栓塞风险因素的相关性
本研究纳入128名受试者,采用[18F]氟化钠PET/CT定量评估左颈总动脉摄取,发现平均SUVmax与心血管及血栓栓塞风险升高相关,并与体力活动水平呈负相关;年龄、BMI、高血压和体力活动是其独立关联因素。
要点
- 左颈总动脉[18F]氟化钠摄取越高,心血管及血栓栓塞风险越高。
- 体力活动水平较高者颈动脉摄取较低,提示运动可能具有保护作用。
- 该技术有望用于早期动脉粥样硬化的分子水平风险评估。
关键影像表现/征象
- 左颈总动脉[18F]氟化钠摄取在心血管事件风险增高患者中显著增高(单因素方差分析,p<0.01)。
- 左颈总动脉[18F]氟化钠摄取在血栓栓塞事件风险增高患者中显著增高(单因素方差分析,p<0.01)。
- 左颈总动脉[18F]氟化钠摄取在体力活动水平较高患者中显著降低(单因素方差分析,p=0.02)。
诊断标准与关键数值
- 采用经血池校正的SUVmax定量评估左颈总动脉[18F]氟化钠摄取,计算所有轴位层面的平均值(aSUVmax)。
- 心血管风险采用Framingham模型估计的10年风险,血栓栓塞风险采用CHA2DS2-VASc评分,体力活动水平(LPA)作为评估指标。
- 多因素线性回归显示年龄(β=0.07,95%CI 0.05-0.10,p<0.01)、BMI(β=0.02,95%CI 0.01-0.03,p<0.01)、高血压(β=0.15,95%CI 0.08-0.23,p<0.01)和LPA(β=-0.10,95%CI -0.19至-0.02,p=0.02)与aSUVmax独立相关。
临床应用与阅片要点
- 阅片时可关注左颈总动脉[18F]氟化钠摄取,高摄取提示心血管及血栓栓塞风险增高。
- 结合患者年龄、BMI、高血压病史及体力活动水平综合解读摄取程度。
- 该技术尚处研究阶段,不能单独用于临床决策,需结合常规风险模型。
局限性
- 原文未明确报告研究设计类型(如回顾性或前瞻性)、单中心或多中心、设备型号及参考标准细节。
- 样本量有限(128例),且为横断面分析,无法确立因果关系。
- 作者指出仍需大型试验进一步验证所发现的关联及其潜在临床价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: There is growing evidence that sodium fluoride ([18F]fluoride) PET/CT can detect active arterial calcifications at the molecular stage. We investigated the relationship between arterial mineralization in the left common carotid artery (LCC) assessed by [18F]fluoride PET/CT and cardiovascular/thromboembolic risk.
METHODS: In total, 128 subjects (mean age 48 ± 14 years, 51% males) were included. [18F]fluoride uptake in the LCC was quantitatively assessed by measuring the blood-pool-corrected maximum standardized uptake value (SUVmax) on each axial slice. Average SUVmax (aSUVmax) was calculated over all slices and correlated with 10-year risk of cardiovascular events estimated by the Framingham model, CHA2DS2-VASc score, and level of physical activity (LPA).
RESULTS: The aSUVmax was significantly higher in patients with increased risk of cardiovascular (one-way ANOVA, p < 0.01) and thromboembolic (one-way ANOVA, p < 0.01) events, and it was significantly lower in patients with greater LPA (one-way ANOVA, p = 0.02). On multivariable linear regression analysis, age ( = 0.07, 95% CI 0.05 - 0.10, p < 0.01), body mass index ( = 0.02, 95% CI 0.01 - 0.03, p < 0.01), arterial hypertension ( = 0.15, 95% CI 0.08 - 0.23, p < 0.01), and LPA ( = -0.10, 95% CI -0.19 to -0.02, p=0.02) were independent associations of aSUVmax.
CONCLUSIONS: Carotid [18F]fluoride uptake is significantly increased in patients with unfavorable cardiovascular and thromboembolic risk profiles. [18F]fluoride PET/CT could become a valuable tool to estimate subjects' risk of future cardiovascular events although still major trials are needed to further evaluate the associations found in this study and their potential clinical usefulness.
KEY POINTS: • Sodium fluoride ([18F]fluoride) PET/CT imaging identifies patients with early-stage atherosclerosis. • Carotid [18F]fluoride uptake is significantly higher in patients with increased risk of cardiovascular and thromboembolic events and inversely correlated with the level of physical activity. • Early detection of arterial mineralization at a molecular level could help guide clinical decisions in the context of cardiovascular risk assessment.
引用
- Castro SA, Muser D, Lee H, et al. Carotid artery molecular calcification assessed by [18F]fluoride PET/CT: correlation with cardiovascular and thromboembolic risk factors. Eur Radiol. 2021. PMID: 33866386. doi:10.1007/s00330-021-07917-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。